Knotnerus Tim Jasper
Reporting owner on Forms 3, 4 and 5, CIK 2120886.
Knotnerus Tim Jasper reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-07.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| AGMB · AgomAb Therapeutics NVCIK 2020932 | director, officer (Chief Executive Officer) | 1 | 2026-10-07 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| AGMB · AgomAb Therapeutics NVCommon shares | 2026-10-06 | P bought | +5,000 | $8.7 | 21,823 | Form 4 |
| AGMB · AgomAb Therapeutics NVCommon shares | 2026-10-05 | P bought | +6,000 | $8.48 | 16,823 | Form 4 |
| AGMB · AgomAb Therapeutics NVCommon shares, holding | 34,394 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0002120886-26-000001 | AgomAb Therapeutics NV | 2026-10-07 |